Use your antibodies-online credentials, if available.
抗Human Angiotensin I Converting Enzyme 1 抗体:
抗Mouse (Murine) Angiotensin I Converting Enzyme 1 抗体:
抗Rat (Rattus) Angiotensin I Converting Enzyme 1 抗体:
Mouse (Murine) Polyclonal Angiotensin I Converting Enzyme 1 Primary Antibody for CyTOF, FACS - ABIN4900261
Park, Bivona, Kobori, Seth, Chappell, Lazartigues, Harrison-Bernard: Major role for ACE-independent intrarenal ANG II formation in type II diabetes. in American journal of physiology. Renal physiology 2009
Show all 3 Pubmed References
Human Polyclonal Angiotensin I Converting Enzyme 1 Primary Antibody for CyTOF, FACS - ABIN4900150
Rockx, Sheahan, Donaldson, Harkema, Sims, Heise, Pickles, Cameron, Kelvin, Baric: Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice. in Journal of virology 2007
Show all 3 Pubmed References
Human Monoclonal Angiotensin I Converting Enzyme 1 Primary Antibody for FACS - ABIN2688976
Sinka, Biasch, Khazaal, Péault, Tavian: Angiotensin-converting enzyme (CD143) specifies emerging lympho-hematopoietic progenitors in the human embryo. in Blood 2012
Show all 3 Pubmed References
Human Monoclonal Angiotensin I Converting Enzyme 1 Primary Antibody for ELISA, WB - ABIN560577
Dekanty, Romero, Bertolin, Thomas, Leishman, Perez-Perri, Boccaccio, Wappner: Drosophila genome-wide RNAi screen identifies multiple regulators of HIF-dependent transcription in hypoxia. in PLoS genetics 2010
Show all 3 Pubmed References
Cat (Feline) Monoclonal Angiotensin I Converting Enzyme 1 Primary Antibody for FACS - ABIN2478516
Danilov, Muzykantov, Martynov, Atochina, Sakharov IYu, Trakht, Smirnov: Lung is the target organ for a monoclonal antibody to angiotensin-converting enzyme. in Laboratory investigation; a journal of technical methods and pathology 1991
Show all 4 Pubmed References
Cat (Feline) Monoclonal Angiotensin I Converting Enzyme 1 Primary Antibody for IHC (fro), FACS - ABIN2478509
Danilov, Jaspard, Churakova, Towbin, Savoie, Wei, Alhenc-Gelas: Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. Selective inhibition of the amino-terminal active site. in The Journal of biological chemistry 1994
Show all 4 Pubmed References
Mouse (Murine) Polyclonal Angiotensin I Converting Enzyme 1 Primary Antibody for WB - ABIN5693158
Yan, Shen: Aliskiren has chondroprotective efficacy in a rat model of osteoarthritis through suppression of the local renin-angiotensin system. in Molecular medicine reports 2018
Human Monoclonal Angiotensin I Converting Enzyme 1 Primary Antibody for FACS - ABIN4897256
Pelosi, Castelli, Martin-Padura, Bordoni, Santoro, Conigliaro, Cerio, De Santis Puzzonia, Marighetti, Biffoni, Alonzi, Amicone, Alcalay, Bertolini, Testa, Tripodi: Human haemato-endothelial precursors: cord blood CD34+ cells produce haemogenic endothelium. in PLoS ONE 2012
Mouse (Murine) Polyclonal Angiotensin I Converting Enzyme 1 Primary Antibody for ELISA (Detection), FACS - ABIN4900259
Spencer, Yang, Haxhija, Wildhaber, Greenson, Teitelbaum: Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition. in Digestive diseases and sciences 2007
The study suggests that the ACE I/D polymorphism may contribute to mechanisms and intensity of DNA damage in hypertensive and normotensive individuals.
study found a significant association between the ACE insertion/deletion polymorphism and Kawasaki disease risk - meta-analysis
ACE gene I/D polymorphism was not associated with the risk of chronic obstructive pulmonary disease.
aerobic exercise training differentially affects the ACE C- and N-domain activities, and the N-domain activity is dependent on ACE polymorphism.
A significant difference was found between the patients with familial Mediterranean fever (FMF)-related amyloidosis and the control group as for genotype distribution of angiotensin converting enzyme (ACE) I/D variant. Based on these observations, the ACE I/D variant D/D genotypes implicate a possible risk in the FMF-related amyloidosis among Turkish population.
Angiotensin-converting enzyme insertion/deletion gene polymorphism is associated with prostate cancer susceptibility.
This study aimed to investigate the relationship between estimated training status (TS), blood pressure and angiotensin-converting enzyme (ACE) activity in elderly people classified as low or high risk to develop hypertension according to genetic profile.
This study shows that ACE gene polymorphism, particularly the D allele, is associated with worse functional outcome of ischaemic stroke patients.
ACE gene polymorphisms were not associated with the development of preeclampsia in South African Black women.
summary of current knowledge about circulating ACE elevation in patients with granulomatous and non-granulomatous diseases.
This study found that patients with the DD genotype reduced the exogenous EPO requirement as compared to the II genotype. Further, D allele frequency was higher in patients with diabetic nephropathy as compared to I allele which implies that D allele is an independent risk factor for progression to CKD.
Prevalence has been found of ACTN3 R577X and of ACE insertion / deletion gene polymorphisms in national and amateur Turkish athletes.
The ACE and AGT gene polymorphisms are not associated with the progress of diabetes developing into retinopathy in Chinese patients with type 2 diabetes.
Review/Meta-analysis: ACE I/D polymorphism may be a genetic molecular marker to predict systemic lupus erythematosus but not lupus nephritis.
Association of insertion/deletion (I/D) polymorphism at angiotensin-converting enzyme gene (ACE) with depression in Chinese adolescents experiencing the 2008 Wenchuan earthquake.
The ACE (I/D) gene polymorphism do not seem to have a significant effect on the development of clinical properties or cardiovascular comordities of acromegalic patients.
polymorphisms in the eNOS "A/A" (homozygous mutant) and ACE "I/D" genotypes might contribute to the increased risk of NSCLC in the South Indian population.
The study attempts to understand the distribution and extent of association of ACE I/D gene polymorphism with cardiometabolic risk factors among Bhils from rural and urban settings.
Data suggest that the insertion/deletion (I/D) ACE (angiotensin converting enzyme) gene polymorphism may be associated with MI occurrence among younger patients.
The analysis of genotype coexistence revealed a higher incidence of the combination of the ACE II and the PAI-1 4G/4G genotypes in the control group (10.0 vs.5.9% in control group; p = 0.17). CONCLUSIONS: The obtained results suggest no apparent association between the ACE I/D, PAI-1 4G/5G polymorphisms and increased RM susceptibility in the analyzed Polish population.
ACE expression/phosphorylation in the bone-marrow niche interface negatively regulates G-CSF-induced signaling and hematopoietic progenitor cell mobilization.
first evidence indicating the causation between ACE DD or B2R+9bp genotype and the increased risk for diabetic nephropathy, broadening our horizon about the role of genetic modulators in this disease.
a small increase in angiotensin-converting enzyme activity in diabetic animals leads to greater impairment of autonomic function, as demonstrated by increased sympathetic modulation and reduced cardiac vagal modulation along with increased renal expression of Ang II.
Resveratrol upregulated ACE2 and inhibited abdominal aortic aneurysm growth in a mouse model.
In mice with renal injury induced by L-NAME pretreatment, renal tubular epithelial ACE is essential for renal angiotensin II accumulation and salt-sensitive hypertension
Studied ACE role in peptide processing and for MHC class II antigen presentation; found ACE level effects efficiency of antigen presentation, and overexpression or inhibition of ACE alters the CD4(+) T-cell and antibody response.
ACE enhances the oxidative response and bactericidal activity of neutrophils.
this study shows that angiotensin-converting enzyme inhibitor captopril rescues mice from endotoxin-induced lethal hepatitis
Smooth muscle cell-derived ACE contributes to atherosclerosis, independent of circulating ACE activity and blood pressure.
Intestinal ACE shedding is increased by DSS-induced intestinal inflammation and parallels local corticosterone production. ACE product angiotensin II stimulates corticosterone formation in healthy intestine.
Renin angiostensin system contributes to 20-HETE-mediated microvascular remodeling in hypertension and that 20-HETE-driven microvascular remodeling independent of blood pressure elevation does not fully rely on ACE activity in the vascular endothelium.
angiotensin-converting enzyme has an essential role in hypertension induced by nitric oxide synthesis inhibition
Suggest that the ACE2-ACE imbalance plays an important role in the pathogenesis of severe acute pancreatitis and that pancreatic ACE2 is an important factor in determining the severity of SAP.
Show that tissue-specific targets are critical for the effects of miR-143/145 on smooth muscle differentiation and that angiotensin converting enzyme is one such target.
Tissue-specific expression of transgenic secreted ACE in vasculature can restore normal kidney functions, but not blood pressure, of Ace-/- mice.
ACE-null mice produce large numbers of myeloid-derived suppressor cells during chronic inflammation.
Myelomonocytic expression of catalytically active ACE, prevents cognitive decline in a murine model of Alzheimer disease.
ACE mediates angiotensin I-induced atherosclerosis, and ACE expression in leukocytes modestly contributes to atherosclerotic development in hypercholesterolemic mice.
TEX101 is a unique specific substrate for ACE that is essential for the production of fertile mouse spermatozoa
renal ACE activity is required to increase local Ang II, to stimulate sodium transport in loop of Henle and the distal nephron, and to induce hypertension
Maintaining the balance of the ACE2/ACE axis is important for inhibiting pulmonary apoptosis during acute pulmonary embolism.
The molecular model shows for the first time the relative orientation of the sACE catalytically active domains and their spatial distance.
Tissue Ang I-II conversion depends exclusively on the ACE C-domain, whereas both domains contribute to conversion by soluble ACE and to bradykinin degradation at tissue sites.
The contributions of the C-domain and N-domain differ between DDs and IIs genotype
Corneal cells express ACE, AT(1) and AT(2)receptors. ACE inhibitor enalapril decreased corneal angiogenesis in VEGF-induced corneal neovascularization. ACE inhibitors may be novel therapy to treat corneal angiogenesis.
Angiotensin-converting enzyme (ACE) residues encompassing 343 to 655 of the germinal form are required for its cleavage-secretion.
a portion of the extracellular region of tACE (containing its catalytic site) is released from bovine sperm during capacitation, and tACE activity may be required for sperm capacitation.
The results indicate that the two active sites within bovine somatic ACE exhibit strong negative cooperativity.
Phorbol 12-myristate 13-acetate (PMA) induced Egr-1 and ATF-2 binding to the ACE promoter, whereas Ets-1 binding was suppressed by PMA.
Precompetition angiotensin converting enzyme (ACE) activity in endurance horses competing in an 80 km event was not associated with either finishing position or heart rates, indicating that the enzyme is not a good predictor of performance.
This research investigated angiotensin-converting enzyme activity in the plasma of racehorses and demonstrated that its activity is increased in horses with higher degrees of hemorrhage and is a promising biomarker for pulmonary hemorrhage.
These results show an increase in ACE activity up to fatigue and a return to baseline values at 30 min post exercise.
The aim of this study was to investigate the correlation between angiotensin-converting enzyme (ACE) activity in the equine endometrium and the degree of endometrial periglandular fibrosis.
This gene encodes an enzyme involved in catalyzing the conversion of angiotensin I into a physiologically active peptide angiotensin II. Angiotensin II is a potent vasopressor and aldosterone-stimulating peptide that controls blood pressure and fluid-electrolyte balance. This enzyme plays a key role in the renin-angiotensin system. Many studies have associated the presence or absence of a 287 bp Alu repeat element in this gene with the levels of circulating enzyme or cardiovascular pathophysiologies. Multiple alternatively spliced transcript variants encoding different isoforms have been identified, and two most abundant spliced variants encode the somatic form and the testicular form, respectively, that are equally active.
, angiotensin I converting enzyme (peptidyl-dipeptidase A) 1
, angiotensin I converting enzyme peptidyl-dipeptidase A 1 transcript
, angiotensin converting enzyme, somatic isoform
, angiotensin-converting enzyme
, dipeptidyl carboxypeptidase 1
, dipeptidyl carboxypeptidase I
, kininase II
, peptidase P
, testicular ECA
, dipeptidyl peptidase
, Dipeptidyl carboxypeptidase 1 (Angiotensin I-converting enzyme)
, angiotensin 1 converting enzyme 1
, angiotensin I converting enzyme 1
, angiotensin I-converting enzyme (Dipeptidyl carboxypeptidase 1)
, Angiotensin-converting enzyme, testis-specific isoform
, dipeptidyl carboxy peptidase 1
, angiotensin converting enzyme
, angiotensin-I converting enzyme
, peptidyl dipeptidase i
, angiotensin I-converting enzyme
, Dipeptidyl carboxypeptidase I
, Kininase II
, LOW QUALITY PROTEIN: angiotensin-converting enzyme